Zhou, H., Wang, Y., Lin, Y., Cai, W., Li, X., & He, X. (2021). Preliminary Efficacy and Safety of Camrelizumab in Combination With XELOX Plus Bevacizumab or Regorafenib in Patients With Metastatic Colorectal Cancer: A Retrospective Study. Frontiers Media S.A.
Style de citation Chicago (17e éd.)Zhou, Hong, Yuehui Wang, Yanfang Lin, Wenjie Cai, Xiaofeng Li, et Xiaomeng He. Preliminary Efficacy and Safety of Camrelizumab in Combination With XELOX Plus Bevacizumab or Regorafenib in Patients With Metastatic Colorectal Cancer: A Retrospective Study. Frontiers Media S.A, 2021.
Style de citation MLA (8e éd.)Zhou, Hong, et al. Preliminary Efficacy and Safety of Camrelizumab in Combination With XELOX Plus Bevacizumab or Regorafenib in Patients With Metastatic Colorectal Cancer: A Retrospective Study. Frontiers Media S.A, 2021.